Achieved approximately 20% U.S. augmentation market share within one year of launch, a milestone management notes took previous entrants nearly a decade to reach. Performance is attributed to a 'super cycle' of innovation addressing decades of stagnant R&D in the breast aesthetics industry, specifically targeting unmet safety and aesthetic needs. Management identifies a 'new era of transparency' on social media as a primary demand driver, with patients increasingly requesting the Motiva brand by name ...